AzTrials
AzTrials

10-13 AgeCircadian IMTNCT07170891

Effects of Inspiratory Muscle Training Combined With Circadian Rhythm-based Running Programs in Children Male Football Players

A study testing Morning Running and IMT and Inspiratory muscle training and evening running in people with 10-13 Age and Inspiratory Muscle Training, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, a parallel two-group pre-test-post-test randomized controlled trial was conducted according to CONSORT guidelines. All participants and their parents were given detailed information about the study before it commenced, and written informed consent was obtained in accordance with the ethical principles… Read more about this study

Who is it for?
Ages 10 to 14 years, men onlyHealthy volunteers can take part
Conditions the study is for
10-13 Age, Inspiratory Muscle Training, Running
What is being tested?
Morning Running and IMT and Inspiratory muscle training and evening running
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 Feb 2025to 20 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 14 years
  • Men only
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Candidates must have at least two years of active football training
  • be between the ages of 10 and 13,
  • be in good general health
  • have no known respiratory or cardiovascular conditions,
  • provide written informed parental consent.

Who cannot join

  • A history of lung disease or a current upper respiratory tract infection,
  • A history of current injury,
  • Medication use that may affect breathing or performance,
  • Individuals with FEV1/FVC<70
  • Participation in similar studies within the last six months

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gumushane Univetsity

    Kelkit, Gümüşhane Province, 29600

Other trials in Turkey (Türkiye)

About this study

In this study, a parallel two-group pre-test-post-test randomized controlled trial was conducted according to CONSORT guidelines. All participants and their parents were given detailed information about the study before it commenced, and written informed consent was obtained in accordance with the ethical principles described in the Declaration of Helsinki. Help was received from a third-level athletics coach for planning and implementing running exercises to be used in the project. The study was designed according to the rules of the Declaration of Helsinki and approved by the ethics committee for scientific research of Gümüşhane University (at its meeting on 20.09.2024 and number 2024/7; decision number E-95674917-108.99-282503). The aim of this study is to investigate the effects of additional inspiratory muscle training (IMT) on exercise tolerance, agility performance, and respiratory parameters in 10-12-year-old male football players who have been training regularly for at least two years, based on their chronotype. A power analysis was conducted using G*Power 3.1 to determine the sample size of the study. The effect size (d) was found to be 1.12 (α = 0.05, 1-β = 0.95, η²p = 0.8). Based on this analysis, it was determined that a minimum of 20 participants per group was required. However, to mitigate potential issues, it was decided to include 25 participants, an additional 25%, in each group.

Participants visited the laboratory three times. During the first visit, the familiarization procedure was performed; participants were administered the Morningness-Eveningness Scale for Children questionnaire and divided into 3 groups according to the results. Then, pulmonary function tests (PFT), maximum inspiratory pressure (MIP), expiratory pressure (MEP), six-minute walk test (6MWT), inspiratory muscle training (IMT), and running training procedures were applied. In the second visit, PFT and MIP-MEP tests, agility and 6MWT tests were performed and their performances were recorded. After the six-week training period, participants' final measurements were taken at the third and final visit. Subsequent to the completion of the six-week training period, the participants' final measurements were obtained during the final visit. The experimental trials were conducted at a consistent time each day, between 9:00 and 12:00. Prior to the commencement of the trials, participants were instructed to abstain from high-intensity physical activity.

The inclusion criteria were as follows: a) Candidates must have at least two years of active football training, b) be between the ages of 10 and 13, c) be in good general health, d) have no known respiratory or cardiovascular conditions, e) provide written informed parental consent. The following criteria were used to determine exclusion from the study: The subject's medical history includes the following: a) A history of lung disease or a current upper respiratory tract infection, b) A history of current injury, c) Medication use that may affect breathing or performance, d)Individuals with FEV1/FVC<70 e) Participation in similar studies within the last six months

Read the detailed description

Body composition measurement The height of the participants was measured using a standard height meter (Seca 769, Seca, Hamburg, Germany) with an accuracy of 0.1 centimeter while leaning against a wall without shoes. Body weight was measured using a digital scale (Beurer, model GS27) with an accuracy of 0.1 kilograms before and after the IMT program, which was itself incorporated into the 6-week running program. The participants' body weight was measured in kilograms (kg) without shoes and wearing shorts and a T-shirt to avoid affecting the results.

The Morningness-Eveningness Scale for Children (MESC) The Morningness-Eveningness Scale for Children (MESC), developed by Carskadon et al. (1993), is a tool designed to assess the daily preferences of school-age children. The scale under consideration consists of 10 items with four or five response options. Scores on the scale range from 10 to 43. Established 21 and 35 as the cut-off points for the scale. A positive correlation has been demonstrated between children's preference for mornings and their score on the scale. That is to say, as the score on the scale increases, the preference for mornings concomitantly increases. Scores ranging from 22 to 34 points are indicative of an intermediate type, while scores of 21 or below are associated with an evening type. Scores of 35 points and above are considered to indicate a morning type. The validity and reliability of the Turkish version of the scale were previously examined by Önder and Beşoluk (2013), who determined a Cronbach's alpha value of 0.72. In the context of the study, subjects who attained scores below 21 points were allocated to the evening group. Those who scored between 22 and 34 points were designated as the control group, which comprised individuals who engaged exclusively in jogging. Subjects who scored 35 points and above were assigned to the morning group.

505 Agility test This test consists of measuring the time taken to complete the last 5 meters of a 15-meter track. The time within the first 10 m from the start of the test is not included in the test score. When the next 5 m distance is passed for the first time, the recording begins and stops when the same distance is covered in return.

Six-Minute Walk Test (6MWT) Protocol The 6MWD test is a reliable and valid functional test that can be used to assess exercise tolerance and endurance in healthy children. The rationale behind our selection of this particular evaluation method stems from its status as the most pragmatic and ergonomic approach to appraising the submaximal extent of functional exercise capacity. The Six Minute Walk Test (6MWT) instructions were provided to all participants by an exercise physiologist. The participants were instructed to walk as fast as possible while maintaining a comfortable pace for the duration of six minutes along a pre-measured straight path. During the test, the assessor recorded the time and provided standardized encouragement at each minute interval. The assessor also tallied the number of laps completed by each participant. At the sixth minute, the participants halted at their position on the path, and the assessor recorded the total distance traversed for the final lap. The evaluator then calculated and recorded the total distance walked over the 6-minute period.

Pulmonary function tests FEV1, FEV1/FVC (Tiffenau index), and FVC capacity were analyzed via a CPFS/D USB spirometer from MGF Diagnostics (Saint Paul, Minnesota, USA). Measurements were taken between 15:00 and 17:00 for all participants to obtain the highest spirometric throughput. Participants with FEV1/FVC <75%, any chronic or pulmonary disease, medication that could affect lung function, or a history of upper respiratory tract infection were excluded from the study. Lung function tests were performed with the partic-ipants in the standing position. During the tests, the participants wore a nose clip and were instructed to hold their lips tightly around the mouthpiece to prevent air from escaping.

Respiratory muscle strength Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were measured via a hand-held portable oral pressure meter (MicroRPM, CareFusion Micro Medical, Kent, UK) according to the American Thoracic Society and European Respiratory Society guidelines. With the appropriate filters and holders in place, the nasal airway was closed with a clip. The mouthpiece assembly included a 1 mm hole to prevent glottic closure and minimize the contribution of the buccinator muscles during inspiration. Inspiratory and expiratory maneuvers were performed in the standing position, with MIP and MEP measurements starting at the residual volume and total lung capacity, respectively, and continuing for at least 1 second. The measurements were repeated until there was a 5% difference between the two best results, and the results were recorded as the mean cm H2O.

Running training The morning running sessions were performed between 08:00 and 10:00, the evening sessions were performed between 18:00 and 20:00, and the control group, which only jogged, performed their sessions between 12:00 and 15:00. The exercise intensity for each participant in the running groups was determined as 50% of their heart rate (HR) calculated using the Karvonen formula: Target HR = [(220 - age - rest HR) × intensity] + rest HR. HR was monitored from the first week of training using a telemetric heart rate monitor (Polar M400, Finland). As environmental conditions can affect airway epithelial responses during high-intensity exercise, all participants performed continuous running exercises on a soccer field in Kelkit, Gümüşhane, Turkey (altitude: 1373m). Each session lasted 50 minutes, including a 10-minute warm-up and cool-down each, and was performed at the set target HR three days per week over a six-week period. All sessions were supervised by trained coaches. Warm-up and cool-down routines included static stretching and light exercises targeting relevant muscle groups. Coaches were responsible for monitoring athletes' running technique and speed, ensuring safety and providing motivation. Both groups were adequately hydrated throughout the sessions to prevent dehydration.

Inspiratory muscle training (IMT) Inspiratory muscle training (IMT) was performed using the POWERbreathe® device (POWER® Breathe Classic, IMT Technologies Ltd., Birmingham, UK). The IMT protocol was administered twice daily, in the morning and evening, for a period of six weeks, with the intervention occurring five days per week. Each training session comprised 30 breathing cycles (totaling 60 breathing cycles per day), and participants performed these exercises separately in the morning and evening. Prior to the administration of the POWERbreathe® device, the resistance setting was calibrated to 40% of the participant's maximum inspiratory pressure (MIP), as reported in the study by Çelikel et al. (2025). The initial MIP value was increased by 10% on a weekly basis. The training sessions were overseen by a certified trainer, who ensured that participants adhered to proper form. The morning IMT sessions were held between 8:00 and 10:00, and the evening sessions were held between 17:00 and 20:00.

Statistical analysis The research data were analyzed via IBM SPSS Statistics 24. Descriptive data are presented as the means and standard deviations. The normality of the data was examined via the Kolmogorov-Smirnov test, which revealed that the data were normally distributed. For parametric data, the dependent group t test (paired samples t test) was used for within-group, pretest, and posttest comparisons, and ANOVA was used for the developmental results obtained using the posttest-pretest difference formula. In addi-tion, in the comparison of paired groups, the effect size was calculated according to Cohen's d formula ((M2 - M1) ⁄ the pooled standard deviation). Moreover, it was interpreted as follows: 0 - 0.19 insignificant, 0.20 - 0.59 small, 0.6 - 1.19 moderate, 1.20 - 1.99 large, and ≥ 2.00 very large. Statistical significance was based on a p value of < 0.05.

Being tested
Morning Running and IMT, Inspiratory muscle training and evening running, Control
Keywords
football players, exercise, agility, running training, circadian rhythm, inspiratory muscle training, performance, Children
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Morning Running and IMTDevice

    Inspiratory muscle training was performed in addition to morning running

  • Inspiratory muscle training and evening runningDevice

    Inspiratory muscle training was performed in addition to evening running

  • ControlOther

    non-exercise group

Study groups in NCT07170891
Study groupRoleWhat they receive
CONTROLActive comparatorno exercise group
Receives: Other: Control
MORNİNG RUNNİNG+IMTActive comparatorInspiratory muscle training was performed in addition to morning running
Receives: Device: Morning Running and IMT
EVENİNG RUNİNG+IMTActive comparatorInspiratory muscle training was performed in addition to evening running
Receives: Device: Inspiratory muscle training and evening running

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Agility (505 Agility Test)

    Agility (505 Agility Test): Change from baseline to 8 weeks.

    Measured: 8 weeks.

  2. 6-Minute Walk Test (6MWT)

    6-Minute Walk Test (6MWT): Change from baseline to 8 weeks.

    Measured: 8 weeks.

Secondary outcomes (2)
  1. Respiratory Muscle Strength

    Maximal Expiratory Pressure (MEP) Maximal Inspiratory Pressure (MIP) Description: Maximal Inspiratory Pressure (MIP): Change from baseline to 8 weeks. Time Frame: 8 weeks.

    Measured: 8 weeks.

  2. Pulmonary Function

    Pulmonary Function (FEV1, FVC, FEV1/FVC): Change from baseline to 8 weeks. Respiratory Parameters

    -Pulmonary Function Tests (PFT): FEV1 (Forced Expiratory Volume in 1 second) FVC (Forced Vital Capacity) FEV1/FVC ratio (Tiffenau index)

    Measured: 8 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2025
  2. Study start5 Feb 2025
  3. Primary completion15 Mar 2025
  4. Study completion20 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
In this study, a parallel two-group pre-test-post-test randomized controlled trial was conducted according to CONSORT guidelines \[14\]. All participants and their parents were given detailed information about the study before it commenced, and written informed consent was obtained in accordance with the ethical principles described in the Declaration of Helsinki. Help was received from a third-level athletics coach for planning and implementing running exercises to be used in the project. The aim of this study is to investigate the effects of additional inspiratory muscle training (IMT) on exercise tolerance, agility performance, and respiratory parameters in 10-12-year-old male football players who have been training regularly for at least two years, based on their chronotype. G\*Power 3.1 to determine the sample size of the study. Based on this analysis, it was determined that a minimum of 20 participants per group was required
Masking
Single blind
Who is masked
Investigator
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07170891
Sponsor's protocol ID
E-95674917-108.99-282503
Acronym
Circadian IMT
Status last verified
Sep 2025
First submitted
20 Jun 2025
Last updated
25 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: THE PERSONAL DATA WILL BE SHARED IF REQUESTED.

Publications

  • Aydin AS, Soyler M, Zileli R, Halmatov M, Gurkan AC, Akcan IO, Yilmaz C. Game-based and individualized movement training improves physiological and motor outcomes in young adults with autism spectrum disorder: an experimental study from Turkiye. BMC Sports Sci Med Rehabil. 2026 Jan 29;18(1):103. doi: 10.1186/s13102-026-01541-y.

    PubMed 41606633

Questions about this trial

What is this clinical trial studying?

A study testing Morning Running and IMT and Inspiratory muscle training and evening running in people with 10-13 Age and Inspiratory Muscle Training, run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Agility (505 Agility Test) (time frame: 8 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07170891, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in